Drug Discovery News
Latest Drug Discovery news and analysis — 16 articles tagged Drug Discovery on The Robotics Media.
- BigHat Biosciences Closes $75M Series C, Pushes AI-Designed ADC Into Phase 1 — — DFJ Growth and Premji Invest co-lead BigHat's $75M Series C as its first Milner-designed antibody, BHB810, doses first patient in gastric cancer trial...
- Basecamp Research Closes $140M Series C To Scale EDEN Foundation Model — — The London biology startup will scale its EDEN 28B-parameter model and Trillion Gene Atlas to design AI-generated gene and cell therapies.
- Orbis Medicines Signs Up To $1.4B Novo Nordisk Deal On Oral Macrocycles — — Copenhagen-Lausanne biotech Orbis Medicines has entered a multi-target drug discovery partnership with Novo Nordisk worth up to US$1.4 billion in upfr...
- Altis Labs Bags $25M Series A For AI Imaging Endpoints In Oncology Trials — — Toronto's Altis Labs closed a US$25 million Series A co-led by OrbiMed and Qiming Venture Partners USA to accelerate its AI imaging endpoint models ac...
- Novo Nordisk Taps Anthropic's Claude Science To Speed Drug Discovery — — Danish drugmaker Novo Nordisk names Anthropic a strategic partner, deploying Claude Science and agentic coding tools across its R&D workflows to short...
- Nutshell Therapeutics Closes Series C1 To Scale AI Allosteric Drug Discovery — — Shanghai-based Nutshell Therapeutics has closed a Series C1 led by Trustbridge Capital and Decheng Capital to scale its machine-learning-plus-physics...
- Faro Closes $37.3M Series B To Push Agentic AI Deeper Into Clinical Trials — — San Diego-based Faro Health raised $37.3M Series B co-led by Merck Global Health Innovation Fund and S32 to scale agentic AI agents across clinical st...
- Claude Designs Protein Binders For 14 Of 15 Targets In Wet-Lab Test — — Anthropic's Claude Mythos Preview and Opus 4.8 autonomously ran a de novo protein binder campaign against 15 targets and produced confirmed binders fo...
- Aureka Bags $100M Series B To Build Biology Foundation Model — — AI-native TechBio startup Aureka Biotechnologies has closed a $100M Series B led by Granite Asia to train its biological foundation model and scale it...
- Dash Bio Raises $30M Series A Led By Oak HC/FT For Automated Bioanalysis — — Boston-based bioanalysis CRO Dash Bio has raised a $30 million Series A led by Oak HC/FT to scale its robotics-driven laboratory and software platform...
- Chai Discovery Raises $400M Series C at $3.8B Valuation for AI Drug Design — — AI drug-discovery startup Chai Discovery has raised a $400M Series C at a $3.8B valuation led by Index Ventures, with Kleiner Perkins, Sequoia Capital...
- Healx Doses First Patient In AI-Designed Sarcoma Trial HLX-4310 — — Cambridge AI-native biotech Healx has dosed the first patient in a Phase 1/2 trial of HLX-4310 — an HDAC-plus-mTOR combination targeting metastatic re...
- Chai Discovery Locks In $400M Series C At $3.8B To Design Molecules With AI — — San Francisco-based Chai Discovery closed a $400M Series C at a $3.8B valuation, led by Index Ventures with Kleiner Perkins, Sequoia Capital, Dimensio...
- Absentia Labs' Digital Liver Becomes First AI Drug Tool Into FDA ISTAND — — Absentia Labs' Digital Liver Model has been accepted into the U.S. FDA's ISTAND qualification pathway, becoming the first AI-driven Drug Development T...
- Takeda Bets Up To $600M On Insilico's Pharma.AI For AI Drug Discovery — — Insilico Medicine signed a strategic collaboration with Takeda worth up to $600 million to use its generative AI Pharma.AI platform to discover clinic...
- Anthropic Unveils Claude Science and Enters Drug Discovery Race — — Anthropic launched Claude Science, a research workbench with 60-plus preconfigured scientific tools, and announced its own drug discovery program for...